Churchill Cap Corp X SEC Filings

Churchill Capital Corp X plans to move its stock market listing from Nasdaq to the New York Stock Exchange in connection with its previously announced business combination with ColdQuanta, Inc. (Infleqtion). The move is contingent on completing the business combination and a re‑domiciling from the Cayman Islands to Delaware.

At closing, each Class A ordinary share will convert one-for-one into common stock, and each public warrant will convert into a warrant for the same number of common shares. Units from the initial public offering will separate into shares and warrants before closing. Trading of the current securities on Nasdaq is expected to end on February 13, 2026, with the new common stock and warrants expected to begin trading on the NYSE on February 17, 2026 under the symbols “INFQ” and “INFQ WS”.

Churchill Capital Corp X is moving forward with its proposed business combination with quantum computing company Infleqtion (ColdQuanta, Inc.). The SEC declared Churchill X’s registration statement on Form S-4 effective on January 23, 2026, clearing the way for shareholder consideration of the deal. Churchill X will hold a shareholder vote on February 12, 2026, and Infleqtion’s CEO expects the combined company’s common stock to trade on Nasdaq under the ticker INFQ in mid-February, if the transaction is completed.

Infleqtion, based in Louisville, focuses on quantum sensing and quantum computing using neutral-atom technology, with about 185 employees and roughly 28 open roles, mostly in engineering. It supplies quantum computers, sensors, RF systems, clocks and navigation solutions to customers that include NASA, Nvidia and the U.S. Department of Defense. The communication also highlights extensive forward-looking statement and risk disclosures, emphasizing technical, regulatory, financing and transaction-completion uncertainties around both the quantum business and the merger with Churchill X.

Churchill Capital Corp X and Infleqtion announced that their joint Form S-4 registration statement for a proposed business combination was declared effective by the SEC on January 23, 2026. Churchill Capital Corp X has scheduled an extraordinary general meeting for February 12, 2026 to seek shareholder approval of the transaction and related matters.

The business combination is expected to deliver over $540 million in gross proceeds, assuming no redemptions of Churchill Capital Corp X shares held in trust, including more than $125 million from a common stock PIPE raised from institutional investors. The combined company would operate as Infleqtion, Inc., be listed on the New York Stock Exchange under the ticker “INFQ,” and is expected to close in Q1 2026, subject to shareholder approval and customary conditions.

Churchill Capital Corp X is asking shareholders to approve its merger with Infleqtion and is registering up to 244,463,410 shares of Post-Closing Company common stock in connection with the deal. The SPAC will domesticate from the Cayman Islands to Delaware and, after a two-step merger, be renamed Infleqtion, Inc., focusing on quantum computing, sensing and software.

Infleqtion holders are slated to receive stock valued at an aggregate $1,800,000,000, paid entirely in shares at $10.00 per Post-Closing Company share, with an estimated exchange ratio of about 0.347 Post‑Closing share for each Infleqtion share. A concurrent PIPE investment of $126,547,600 at $10.00 per share will provide additional capital.

Pro forma, Infleqtion stockholders would hold about 69.9% of the combined company in a no‑redemption case and 86.6% under maximum redemptions, with public shareholders potentially redeemed out entirely in the maximum redemption scenario. CCX public shareholders may redeem their Class A shares for cash from the trust account, subject to a 15% per‑holder cap, and are being asked to vote on the business combination and related governance, stock issuance, incentive plan, ESPP, director and adjournment proposals. The combined company intends to list on the NYSE under the symbol INFQ.

Churchill Capital Corp X (CCCX) has filed Amendment No. 2 to its Form S-4 to register up to 244,463,410 shares of common stock to be issued in connection with its proposed business combination with ColdQuanta, Inc. (d/b/a Infleqtion). CCCX will domesticate from the Cayman Islands to Delaware and, through a two-step merger, Infleqtion will become a wholly owned subsidiary and the combined public company will be renamed “Infleqtion, Inc.”

The merger values Infleqtion at an aggregate Equity Value of $1,800,000,000, paid entirely in stock at $10.00 per share, implying an estimated exchange ratio of about 0.347 new shares for each Infleqtion common share. A concurrent PIPE Investment will provide $126,547,600 of CCCX common stock at $10.00 per share. Pro forma ownership under no-redemption and maximum-redemption cases ranges from 214,924,762 to 173,524,762 shares outstanding, with Infleqtion holders owning the majority in both scenarios. CCCX’s board unanimously approved the deal, supported by a fairness opinion from Ocean Tomo, and is calling a shareholder meeting on February 12, 2026, while seeking to list the new Infleqtion, Inc. shares on the NYSE under the symbol “INFQ.”

Churchill Capital Corp X has filed an amended Form S-4 for its proposed business combination with quantum technology company ColdQuanta, Inc. (d/b/a Infleqtion). This proxy statement/prospectus covers up to 244,463,410 shares of common stock of the post-closing company to be issued in connection with the merger and related transactions.

The deal values Infleqtion at an equity value of $1.8 billion, to be paid entirely in post-closing common stock at $10.00 per share, with an estimated exchange ratio of about 0.347 post-closing shares for each Infleqtion common share. CCX has also arranged a $126,547,600 PIPE investment at $10.00 per share to help fund the transaction.

Following the deal, CCX will domesticate from the Cayman Islands to Delaware and be renamed Infleqtion, Inc. Pro forma, Infleqtion stockholders are expected to hold the majority of the combined company, with SPAC public holders, the sponsor and PIPE investors owning the balance under various redemption scenarios. The CCX board unanimously approved the merger and received a fairness opinion supporting the purchase price.

Churchill Capital Corp X filed this communication to highlight its proposed business combination with quantum technology company ColdQuanta, Inc. (Infleqtion) through a Nasdaq MarketSite interview with Infleqtion’s CEO, Matt Kinsella. He explains that Infleqtion uses room-temperature neutral-atom technology to build quantum products such as precision clocks, RF antennas, sensors and, longer term, quantum computers.

Kinsella describes current products that already show large performance gains over classical systems and notes that Infleqtion has announced 12 logical qubits, with a goal of reaching around 100 logical qubits to enable new materials and chemistry applications, and later 1,000 for areas like drug discovery. Over the next 12–24 months, Infleqtion aims to grow revenue from sensing products and continue selling quantum computing systems while advancing toward quantum advantage in computing.

The communication also explains that Churchill will file a Form S-4 registration statement with a proxy statement/prospectus for shareholders to vote on the business combination and emphasizes detailed forward‑looking statement and risk disclosures, urging Churchill and Infleqtion shareholders to read those materials once available.

Churchill Capital Corp X has filed a communication about its proposed business combination with quantum technology company ColdQuanta, Inc. (Infleqtion) and the plan to take Infleqtion public. In a detailed interview, Infleqtion’s CEO describes a platform built on neutral atom quantum technology used for precision clocks, sensors and quantum computers, all operating at room temperature through laser-controlled atomic systems.

The discussion highlights applications in GPS‑independent timing, national security, cryptography, drug discovery, AI acceleration and space-based quantum systems, including work with NASA and U.S. defense customers. Management emphasizes that Infleqtion is already selling quantum sensing products and intends to use new capital from going public to accelerate commercialization and reach logical qubits that can unlock quantum advantage in areas like materials science and advanced computing.

Churchill Capital Corp X filed its quarterly report, highlighting its May IPO of 41.4 million units at $10.00 and a Trust Account balance of $419.6 million at redemption value as of September 30, 2025. The company reported a Q3 net loss of $33.4 million, driven mainly by a non-cash $30.5 million loss from the change in fair value of a subscription agreement liability and $6.0 million of subscription agreement expense, partly offset by $4.4 million of interest income on Trust investments.

Churchill entered a definitive Merger Agreement on September 8, 2025 to combine with ColdQuanta, Inc. and signed PIPE subscription agreements for $126.5 million at $10.00 per share, recorded as a $36.5 million liability at quarter-end. Liquidity at September 30, 2025 included cash of $1.14 million and a working capital deficit of $35.2 million. As of November 12, 2025, shares outstanding were 41,700,000 Class A and 10,350,000 Class B, with 10,350,000 public warrants outstanding.